St. Jude gets approval for quadripolar pacing system for CRT-Ds in India; FDA warns of fracture risk with cat vax device;

> St. Jude Medical ($STJ) has received approval for the industry's first quadripolar pacing system for cardiac resynchronization therapy defibrillators in India. St. Jude release

> The FDA is warning vets and cat owners of the possible fracture risk associated with Bioject's Vet Jet transdermal vaccination system device. The product is sold exclusively as the delivery system for Merial's PUREVAX recombinant feline leukemia vaccine. Three adverse event reports have been reported; in two of the cases, the user failed or may have failed to properly lock the nozzle into the device before using it. News

> AmerisourceBergen ($ABC) has completed the acquisition of Premier Source, which provides consulting and reimbursement services to medical device, pharmaceutical, molecular diagnostic and biotechnology manufacturers. The financial terms of the transaction were not disclosed. AmerisourceBergen release

> Tufts University scientists have developed a single molecule electric motor that measures a 1-nanometer across. "Once we have a better grasp on the temperatures necessary to make these motors function, there could be real-world application in some sensing and medical devices which involve tiny pipes," says Professor Charles Sykes. Item

> High sensitivity magnetic sensors are important for monitoring heart and brain activities and may possibly provide early warning of life-threatening diseases and malfunction. Researchers at the Toyohashi University of Technology in Japan have developed magnetic sensors using magnonic crystals--artificial magnetic crystal structures capable of controlling the propagation of magnetostatic waves. Story

And Finally... For decades, transporting hearts for the purpose of transplantation has been accomplished with little more than coolers and ice. However, now members of UCLA's lung and heart-lung transplant team is seeing if they can bring the field of heart transplantation into the 21st century by transporting donor hearts in a beating state (with video). Report

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.